PTC Therapeutics IncPTC Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The ESG rating for PTC Therapeutics Inc represents the company's transparency towards the UN Sustainable Development Goals. This ESG score includes 17 United Nations SDGs including: 'Quality Education', 'Responsible Production & Consumption' and 'Partnerships for the Goals'. The webpage includes a questions and answers table about PTC Therapeutics Inc.

PTC Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.1; made up of an environmental score of 1.1, social score of 6.0 and governance score of 5.0.

SDG Transparency Score for PTC Therapeutics Inc 
Low
0 - 3

4.1

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for PTC Therapeutics Inc 
1.1

Environmental

6.0

Social

5.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1376Vericel Corp
4.2
High
1376vTv Therapeutics Inc
4.2
High
1412PTC Therapeutics Inc
4.1
High
1412Abivax SA
4.1
High
1412Aeglea Bio Therapeutics Inc
4.1
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does PTC Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does PTC Therapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does PTC Therapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does PTC Therapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does PTC Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does PTC Therapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does PTC Therapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does PTC Therapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did PTC Therapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does PTC Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has PTC Therapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does PTC Therapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does PTC Therapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is PTC Therapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does PTC Therapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does PTC Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does PTC Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for PTC Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Sorry!

Failed to process!